Medicines (Rx)
- 2017
- ~
- 2022
- PhytoHealth PG2® Injection officially covered under Taiwan National Health Insurance(NHI)
- PhytoHealth PG2® Injection obtained patent approval for cancer immunotherapy in Taiwan and Korea
- AmazPower® awarded Symbol of National Quality(SNQ, 2020)
- Oraphine® awarded Silver Medal(The highest honor) in Pharmaceutical Science and Technology Research and Development Award (Drug Category, 2020)
- PhytoHealth PG2® Injection awarded Symbol of National Quality(SNQ, 2019)
- Qi+ Liqiud Herbal Engergy® officially launch
- 2011
- ~
- 2016
- Botanical Active Pharmaceutical Ingredients(API) Manufacturing Facility obtained TFDA PIC/S GMP approval
- PHN033 selected as the Cross-Strait Drug Co-Development Project
- PHN031 selected as the Cross-Strait New Drug Co-Development case
- PhytoHealth PG2® Injection officially launch
- PHN033 awarded the National innovation award
- 2000
- ~
- 2010
- PhytoHealth PG2® Injection awarded the National Biotechnology & Medical Care Quality Award
- Oraphine® PHN131 awarded the National innovation award
- PhytoHealth PG2® Injection awarded Gold Medal in Taipei City of Bio-Driven(Technological Commercialization Category,2008)
- PHN031 awarded Silver Medalin Taipei City of Bio-Driven (R&D Innovation Category,2008)
- PhytoHealth PG2® Injection License issued by TFDA
- PHN033 reviewed by the US FDA and obtained approval for clinical Phase II trials
- PhytoHealth PG2® Injection reviewed by the US FDA and obtained approval of IND for clinical Phase II trials
- 1st Publicly Listed BioPharm Company in Taiwan
- 1998
- Founded